+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Bioartificial liver system based on choanoid fluidized bed bioreactor improve the survival time of fulminant hepatic failure pigs



Bioartificial liver system based on choanoid fluidized bed bioreactor improve the survival time of fulminant hepatic failure pigs



Biotechnology and Bioengineering 108(9): 2229-2236



Bioartificial liver (BAL) support system has been proposed as potential treatment method for end-stage liver diseases. We described an improved BAL system based on a choanoid fluidized bed bioreactor containing alginate-chitosan encapsulated primary porcine hepatocytes. The feasibility, safety, and efficiency of this device were estimated using an allogeneic fulminant hepatic failure (FHF) model. FHF was induced with intravenous administration of D-galactosamine. Thirty FHF pigs were divided into three groups: (1) an FHF group which was only given intensive care; (2) a sham BAL group which was treated with the BAL system with empty encapsulation, and (3) a BAL group which was treated with the BAL system containing encapsulated freshly isolated primary porcine hepatocytes. The survival times and biochemical parameters of these animals were measured, and properties of the encapsulations and hepatocytes before and after perfusion were also evaluated. Compared to the two control groups, the BAL-treated group had prolonged the survival time and decreased the blood lactate levels, blood glucose, and amino acids remained stable. No obvious ruptured beads or statistical decline in viability or function of encapsulated hepatocytes were observed. This new fluidized bed BAL system is safe and efficient. It may represent a feasible alternative in the treatment of liver failure.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051798955

Download citation: RISBibTeXText

PMID: 21455934

DOI: 10.1002/bit.23150


Related references

Significant survival prolongation in pigs with fulminant hepatic failure treated with a novel microgravity-based bioartificial liver. Artificial Organs 30(12): 906-914, 2006

Bioartificial liver treatment prolongs survival and lowers intracranial pressure in pigs with fulminant hepatic failure. Artificial Organs 25(7): 566-570, 2001

Evaluation of a novel choanoid fluidized bed bioreactor for future bioartificial livers. World Journal of Gastroenterology 20(22): 6869-6877, 2014

Bioartificial liver treatment prevents development of intracranial hypertension in pigs with fulminant hepatic failure. Hepatology 28(4 Part 2): 171A, 1998

Comparative study of bioartificial liver support and plasma exchange for treatment of pigs with fulminant hepatic failure. Artificial Organs 24(4): 265-270, 2000

In vivo efficacy of a bioartificial liver in improving spontaneous recovery from fulminant hepatic failure: a controlled study in pigs. Transplantation 69(3): 337-344, 2000

Treatment of fulminant hepatic failure rats with a bioartificial liver prolongs survival and improves HGF c-met - TGF-beta-1 balance. Hepatology 26(4 Part 2): 167A, 1997

The influence of serum from fulminant hepatic failure to hepatocyte in bioartificial liver system. International Journal of Artificial Organs 26(7): 604, 2003

Influence of Serum from Rats with Fulminant Hepatic Failure on Hepatocytes in a Bioartificial Liver System. The International Journal of Artificial Organs 27(4): 303-310, 2004

Influence of serum from rats with fulminant hepatic failure on hepatocytes in a bioartificial liver system. International Journal of Artificial Organs 27(4): 303-310, 2004

Effect of extracorporeal bioartificial liver support system on fulminant hepatic failure rabbits. World Journal of Gastroenterology 6(2): 252-254, 2000

Preclinical trial of a bioartificial liver support system in a porcine fulminant hepatic failure model. Australian and new Zealand Journal of Surgery 66(8): 547-552, 1996

Positive biochemical effects of a bioartificial liver support system in a porcine fulminant hepatic failure model. International Journal of Artificial Organs 21(1): 43-48, 1998

Increased survival in fulminant hepatic failure rats following treatment with the UCLA bioartificial liver support device that utilizes microencapsulated porcine hepatocytes. Gastroenterology 110(4 Suppl. ): A1182, 1996

A new concept of bioartificial liver based on a fluidized bed bioreactor. Therapeutic Apheresis 3(3): 264-267, 1999